Compare RXST & DFP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RXST | DFP |
|---|---|---|
| Founded | 1997 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 366.3M | 429.0M |
| IPO Year | 2021 | N/A |
| Metric | RXST | DFP |
|---|---|---|
| Price | $8.39 | $21.68 |
| Analyst Decision | Hold | |
| Analyst Count | 11 | 0 |
| Target Price | ★ $11.40 | N/A |
| AVG Volume (30 Days) | ★ 1.3M | 56.2K |
| Earning Date | 02-24-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 6.73% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $142,085,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $3.75 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 10.75 | N/A |
| 52 Week Low | $6.32 | $15.45 |
| 52 Week High | $34.70 | $19.31 |
| Indicator | RXST | DFP |
|---|---|---|
| Relative Strength Index (RSI) | 33.25 | 73.43 |
| Support Level | $7.73 | $21.52 |
| Resistance Level | $9.45 | $21.39 |
| Average True Range (ATR) | 0.52 | 0.14 |
| MACD | -0.11 | 0.05 |
| Stochastic Oscillator | 16.56 | 100.00 |
RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture and sale of light adjustable lenses and related capital equipment.
Flaherty & Crumrine Dynamic Preferred and Income Fund Inc is a diversified, closed-end management investment company. Its investment objective is to seek total return, with an emphasis on high current income.